{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:00:07Z","timestamp":1789052407929,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,5,8]],"date-time":"2017-05-08T00:00:00Z","timestamp":1494201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,5,8]],"date-time":"2017-05-08T00:00:00Z","timestamp":1494201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Pneumocystis jirovecii<\/jats:italic> pneumonia (PJP) is a potentially life-threatening infection that occurs in immunocompromised patients. The aim of this study was to evaluate risk factors for PJP in kidney transplantation recipients. We conducted a retrospective analysis of patient data from 500 consecutive kidney transplants performed at Severance Hospital between April 2011 and April 2014. Eighteen kidney transplantation recipients (3.6%) were diagnosed with PJP. In the univariate analysis, acute graft rejection, CMV infection, use of medication for diabetes mellitus, and lowest lymphocyte count were associated with PJP. Recipients who experienced acute graft rejection (odds ratio [OR] 11.81, 95% confidence interval [CI] 3.06\u201345.57, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) or developed CMV infection (OR 5.42, 95% CI 1.69\u201317.39, <jats:italic>P<\/jats:italic>\u2009=\u20090.005) had high odds of PJP in multivariate analysis. In the acute graft rejection subgroup, patients treated with anti-thymocyte globulin (ATG) had significantly higher odds of PJP (OR 5.25, 95% CI 1.01\u201327.36, <jats:italic>P<\/jats:italic>\u2009=\u20090.006) than those who were not. Our data suggest that acute graft rejection and CMV infection may be risk factors for PJP in kidney transplant patients. The use of ATG for acute graft rejection may increase the risk of PJP.<\/jats:p>","DOI":"10.1038\/s41598-017-01818-w","type":"journal-article","created":{"date-parts":[[2017,5,2]],"date-time":"2017-05-02T13:46:22Z","timestamp":1493732782000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Risk factors for Pneumocystis jirovecii pneumonia (PJP) in kidney transplantation recipients"],"prefix":"10.1038","volume":"7","author":[{"given":"Su Hwan","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu Ha","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8405-1531","authenticated-orcid":false,"given":"Dong Jin","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myoung Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon Il","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moo Suk","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Sam","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Kyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Seun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song Yee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,8]]},"reference":[{"key":"1818_CR1","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1056\/NEJMra032588","volume":"350","author":"CF Thomas Jr.","year":"2004","unstructured":"Thomas, C. F. Jr. & Limper, A. H. Pneumocystis pneumonia. N Engl J Med \n                           350, 2487\u20132498, doi:10.1056\/NEJMra032588 (2004).","journal-title":"N Engl J Med"},{"key":"1818_CR2","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1001\/archinte.1995.00430110015002","volume":"155","author":"KA Sepkowitz","year":"1995","unstructured":"Sepkowitz, K. A., Brown, A. E. & Armstrong, D. Pneumocystis carinii pneumonia without acquired immunodeficiency syndrome. More patients, same risk. Arch Intern Med \n                           155, 1125\u20131128, doi:10.1001\/archinte.1995.00430110015002 (1995).","journal-title":"Arch Intern Med"},{"key":"1818_CR3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1034\/j.1399-3062.2003.00018.x","volume":"5","author":"M Radisic","year":"2003","unstructured":"Radisic, M. et al. Risk factors for Pneumocystis carinii pneumonia in kidney transplant recipients: a case-control study. Transpl Infect Dis \n                           5, 84\u201393, doi:10.1034\/j.1399-3062.2003.00018.x (2003).","journal-title":"Transpl Infect Dis"},{"key":"1818_CR4","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1099\/jmm.0.043984-0","volume":"61","author":"PV Coyle","year":"2012","unstructured":"Coyle, P. V. et al. Rising incidence of Pneumocystis jirovecii pneumonia suggests iatrogenic exposure of immune-compromised patients may be becoming a significant problem. J Med Microbiol \n                           61, 1009\u20131015, doi:10.1099\/jmm.0.043984-0 (2012).","journal-title":"J Med Microbiol"},{"key":"1818_CR5","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1086\/515126","volume":"28","author":"SM Gordon","year":"1999","unstructured":"Gordon, S. M. et al. Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued? Clin Infect Dis \n                           28, 240\u2013246, doi:10.1086\/cid.1999.28.issue-2 (1999).","journal-title":"Clin Infect Dis"},{"key":"1818_CR6","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1378\/chest.128.2.573","volume":"128","author":"E Festic","year":"2005","unstructured":"Festic, E., Gajic, O., Limper, A. H. & Aksamit, T. R. Acute respiratory failure due to pneumocystis pneumonia in patients without human immunodeficiency virus infection: outcome and associated features. Chest \n                           128, 573\u2013579, doi:10.1378\/chest.128.2.573 (2005).","journal-title":"Chest"},{"key":"1818_CR7","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1086\/339548","volume":"34","author":"KA Sepkowitz","year":"2002","unstructured":"Sepkowitz, K. A. Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome. Clin Infect Dis \n                           34, 1098\u20131107, doi:10.1086\/cid.2002.34.issue-8 (2002).","journal-title":"Clin Infect Dis"},{"key":"1818_CR8","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/ki.2009.377","volume":"77","author":"BL Kasiske","year":"2010","unstructured":"Kasiske, B. L. et al. KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int \n                           77, 299\u2013311, doi:10.1038\/ki.2009.377 (2010).","journal-title":"Kidney Int"},{"key":"1818_CR9","unstructured":"European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.7.1 Late infections. Pneumocystis carinii pneumonia. Nephrol Dial Transplant \n                           17 Suppl 4, 36\u201339 (2002)."},{"issue":"Suppl 4","key":"1818_CR10","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/ajt.12119","volume":"13","author":"SI Martin","year":"2013","unstructured":"Martin, S. I. & Fishman, J. A. Pneumocystis pneumonia in solid organ transplantation. Am J Transplant \n                           13(Suppl 4), 272\u2013279, doi:10.1111\/ajt.2013.13.issue-s4 (2013).","journal-title":"Am J Transplant"},{"key":"1818_CR11","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1097\/00007890-198903000-00032","volume":"47","author":"RM Higgins","year":"1989","unstructured":"Higgins, R. M., Bloom, S. L., Hopkin, J. M. & Morris, P. J. The risks and benefits of low-dose cotrimoxazole prophylaxis for Pneumocystis pneumonia in renal transplantation. Transplantation \n                           47, 558\u2013560, doi:10.1097\/00007890-198903000-00032 (1989).","journal-title":"Transplantation"},{"key":"1818_CR12","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1093\/ndt\/gfr048","volume":"26","author":"GH Struijk","year":"2011","unstructured":"Struijk, G. H. et al. Risk of Pneumocystis jiroveci pneumonia in patients long after renal transplantation. Nephrol Dial Transplant \n                           26, 3391\u20133398, doi:10.1093\/ndt\/gfr048 (2011).","journal-title":"Nephrol Dial Transplant"},{"key":"1818_CR13","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1093\/ndt\/gfq689","volume":"26","author":"F Eitner","year":"2011","unstructured":"Eitner, F. et al. Risk factors for Pneumocystis jiroveci pneumonia (PcP) in renal transplant recipients. Nephrol Dial Transplant \n                           26, 2013\u20132017, doi:10.1093\/ndt\/gfq689 (2011).","journal-title":"Nephrol Dial Transplant"},{"key":"1818_CR14","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/j.1399-3062.2011.00691.x","volume":"13","author":"N Goto","year":"2011","unstructured":"Goto, N. & Oka, S. Pneumocystis jirovecii pneumonia in kidney transplantation. Transpl Infect Dis \n                           13, 551\u2013558, doi:10.1111\/tid.2011.13.issue-6 (2011).","journal-title":"Transpl Infect Dis"},{"key":"1818_CR15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/TP.0b013e3181aad256","volume":"88","author":"RT Neff","year":"2009","unstructured":"Neff, R. T. et al. Analysis of USRDS: incidence and risk factors for Pneumocystis jiroveci pneumonia. Transplantation \n                           88, 135\u2013141, doi:10.1097\/TP.0b013e3181aad256 (2009).","journal-title":"Transplantation"},{"key":"1818_CR16","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.transproceed.2008.10.027","volume":"41","author":"N Arichi","year":"2009","unstructured":"Arichi, N. et al. Cluster outbreak of Pneumocystis pneumonia among kidney transplant patients within a single center. Transplant Proc \n                           41, 170\u2013172, doi:10.1016\/j.transproceed.2008.10.027 (2009).","journal-title":"Transplant Proc"},{"key":"1818_CR17","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/j.1399-3062.2011.00645.x","volume":"13","author":"MG de Boer","year":"2011","unstructured":"de Boer, M. G. et al. Risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients and appraisal of strategies for selective use of chemoprophylaxis. Transpl Infect Dis \n                           13, 559\u2013569, doi:10.1111\/tid.2011.13.issue-6 (2011).","journal-title":"Transpl Infect Dis"},{"key":"1818_CR18","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nrmicro1621","volume":"5","author":"CF Thomas Jr.","year":"2007","unstructured":"Thomas, C. F. Jr. & Limper, A. H. Current insights into the biology and pathogenesis of Pneumocystis pneumonia. Nat Rev Microbiol \n                           5, 298\u2013308, doi:10.1038\/nrmicro1621 (2007).","journal-title":"Nat Rev Microbiol"},{"key":"1818_CR19","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1111\/j.1469-0691.2010.03400.x","volume":"17","author":"A Alanio","year":"2011","unstructured":"Alanio, A. et al. Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients. Clin Microbiol Infect \n                           17, 1531\u20131537, doi:10.1111\/j.1469-0691.2010.03400.x (2011).","journal-title":"Clin Microbiol Infect"},{"key":"1818_CR20","doi-asserted-by":"publisher","unstructured":"Desoubeaux, G. et al. Use of calcofluor-blue brightener for the diagnosis of Pneumocystis jirovecii pneumonia in bronchial-alveolar lavage fluids: A single-center prospective study. Med Mycol, doi:10.1093\/mmy\/myw068. (2016).","DOI":"10.1093\/mmy\/myw068."},{"key":"1818_CR21","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1016\/j.transproceed.2013.02.107","volume":"45","author":"S Borstnar","year":"2013","unstructured":"Borstnar, S. et al. Pneumocystis jirovecii pneumonia in renal transplant recipients: a national center experience. Transplant Proc \n                           45, 1614\u20131617, doi:10.1016\/j.transproceed.2013.02.107 (2013).","journal-title":"Transplant Proc"},{"key":"1818_CR22","doi-asserted-by":"publisher","first-page":"E23","DOI":"10.1111\/j.1399-3062.2012.00738.x","volume":"14","author":"AH Muhammad Iqbal","year":"2012","unstructured":"Muhammad Iqbal, A. H. et al. Pneumocystis jirovecii pneumonia 13 years post renal transplant following a recurrent cytomegalovirus infection. Transpl Infect Dis \n                           14, E23\u201326, doi:10.1111\/tid.2012.14.issue-4 (2012).","journal-title":"Transpl Infect Dis"},{"key":"1818_CR23","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.humimm.2004.02.012","volume":"65","author":"A Harari","year":"2004","unstructured":"Harari, A., Zimmerli, S. C. & Pantaleo, G. Cytomegalovirus (CMV)-specific cellular immune responses. Hum Immunol \n                           65, 500\u2013506, doi:10.1016\/j.humimm.2004.02.012 (2004).","journal-title":"Hum Immunol"},{"key":"1818_CR24","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/00007890-199608150-00022","volume":"62","author":"V Lufft","year":"1996","unstructured":"Lufft, V. et al. Incidence of Pneumocystis carinii pneumonia after renal transplantation. Impact of immunosuppression. Transplantation \n                           62, 421\u2013423, doi:10.1097\/00007890-199608150-00022 (1996).","journal-title":"Transplantation"},{"issue":"Suppl 4","key":"1818_CR25","doi-asserted-by":"publisher","first-page":"S227","DOI":"10.1111\/j.1600-6143.2009.02914.x","volume":"9","author":"SI Martin","year":"2009","unstructured":"Martin, S. I. & Fishman, J. A. Pneumocystis pneumonia in solid organ transplant recipients. Am J Transplant \n                           9(Suppl 4), S227\u2013233, doi:10.1111\/j.1600-6143.2009.02914.x (2009).","journal-title":"Am J Transplant"},{"key":"1818_CR26","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1086\/513988","volume":"175","author":"HS Oz","year":"1997","unstructured":"Oz, H. S. & Hughes, W. T. Novel anti-Pneumocystis carinii effects of the immunosuppressant mycophenolate mofetil in contrast to provocative effects of tacrolimus, sirolimus, and dexamethasone. J Infect Dis \n                           175, 901\u2013904, doi:10.1086\/jid.1997.175.issue-4 (1997).","journal-title":"J Infect Dis"},{"key":"1818_CR27","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1093\/clinids\/22.6.920","volume":"22","author":"SM Arend","year":"1996","unstructured":"Arend, S. M. et al. Rejection treatment and cytomegalovirus infection as risk factors for Pneumocystis carinii pneumonia in renal transplant recipients. Clin Infect Dis \n                           22, 920\u2013925, doi:10.1093\/clinids\/22.6.920 (1996).","journal-title":"Clin Infect Dis"},{"key":"1818_CR28","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/nep.12201","volume":"19","author":"N Mitsides","year":"2014","unstructured":"Mitsides, N. et al. Complications and outcomes of trimethoprim-sulphamethoxazole as chemoprophylaxis for pneumocystis pneumonia in renal transplant recipients. Nephrology (Carlton) \n                           19, 157\u2013163, doi:10.1111\/nep.2014.19.issue-3 (2014).","journal-title":"Nephrology (Carlton)"},{"key":"1818_CR29","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1128\/jcm.28.11.2432-2436.1990","volume":"28","author":"P Cregan","year":"1990","unstructured":"Cregan, P. et al. Comparison of four methods for rapid detection of Pneumocystis carinii in respiratory specimens. J Clin Microbiol \n                           28, 2432\u20132436 (1990).","journal-title":"J Clin Microbiol"},{"key":"1818_CR30","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.2741\/A363","volume":"3","author":"RP Baughman","year":"1998","unstructured":"Baughman, R. P. & Liming, J. D. Diagnostic strategies in Pneumocystis carinii pneumonia. Front Biosci \n                           3, e1\u201312, doi:10.2741\/A363 (1998).","journal-title":"Front Biosci"},{"key":"1818_CR31","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1164\/ajrccm\/140.5.1204","volume":"140","author":"AH Limper","year":"1989","unstructured":"Limper, A. H., Offord, K. P., Smith, T. F. & Martin, W. J. 2nd Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis \n                           140, 1204\u20131209, doi:10.1164\/ajrccm\/140.5.1204 (1989).","journal-title":"Am Rev Respir Dis"},{"key":"1818_CR32","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1046\/j.1365-2141.2002.03419.x","volume":"117","author":"L Pagano","year":"2002","unstructured":"Pagano, L. et al. Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years\u2019 experience of infection in GIMEMA centres. Br J Haematol \n                           117, 379\u2013386, doi:10.1046\/j.1365-2141.2002.03419.x (2002).","journal-title":"Br J Haematol"},{"key":"1818_CR33","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1378\/chest.08-1309","volume":"135","author":"E Azoulay","year":"2009","unstructured":"Azoulay, E. et al. Polymerase chain reaction for diagnosing pneumocystis pneumonia in non-HIV immunocompromised patients with pulmonary infiltrates. Chest \n                           135, 655\u2013661, doi:10.1378\/chest.08-1309 (2009).","journal-title":"Chest"},{"key":"1818_CR34","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1586\/eri.10.42","volume":"8","author":"EJ Calderon","year":"2010","unstructured":"Calderon, E. J., Gutierrez-Rivero, S., Durand-Joly, I. & Dei-Cas, E. Pneumocystis infection in humans: diagnosis and treatment. Expert Rev Anti Infect Ther \n                           8, 683\u2013701, doi:10.1586\/eri.10.42 (2010).","journal-title":"Expert Rev Anti Infect Ther"},{"key":"1818_CR35","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.diagmicrobio.2009.04.009","volume":"64","author":"W Jiancheng","year":"2009","unstructured":"Jiancheng, W. et al. Screening Pneumocystis carinii pneumonia in non-HIV-infected immunocompromised patients using polymerase chain reaction. Diagn Microbiol Infect Dis \n                           64, 396\u2013401, doi:10.1016\/j.diagmicrobio.2009.04.009 (2009).","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01818-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01818-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01818-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T04:03:41Z","timestamp":1671768221000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01818-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,8]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["1818"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-01818-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,8]]},"assertion":[{"value":"17 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1571"}}